|Unit Price:||USD 1.0000 / Kilogram |
|Min. Order:||1 Kilogram|
|Delivery Time:||15 Days|
Model No.: 204656-20-2
Packaging: AS REQUIRED
Place of Origin: CHINA
Supply Ability: TRUE MANUFACTURER
Certificate: GMP Peptide
We have engaged in offering Liraglutide (NN2211) CAS 204656-20-2 for many years. Liraglutide is a once-daily injectable derivative of the human incretin (metabolic hormone) glucagon-like peptide-1 (GLP-1). Liraglutide 204656-20-2 like a panacea that widely used to treat type 2 diabetes and obesity.
Cas No.: 204656-20-2
Synonyms: Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
Molecular Formula: C172H265N43O51
Packing: Export worthy packing
Material Safety Data Sheet: Available on request
Usage: Liraglutide (CAS 204656-20-2) is one API approved by EU/FDA for the treatment of diabetes,
Liraglutide (CAS 204656-20-2) is a long-acting glucagon-like peptide-1 agonist (GLP-1 agonist). It can be used in the treatment of type 2 diabetes. Liraglutide (CAS 204656-20-2) has been formulated into finished dosage forms and marketed under the trade name of Victoza by Novo Nordisk Pharma.
It has been approved by the European Medicines Agency on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010.